当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3742282
已选条件
-
T6619Desmethyl Erlotinib hydrochlorideDesmethyl Erlotinib hydrochloride,CP 373420,inhibit,CP-373420,Inhib
OSI-420 (Desmethyl Erlotinib, CP-473420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM for human EGFR and EGFR autophosphorylation in tumor cells.
价 格:¥电议型 号:T6619产 地:中国大陆
-
T6328Desmethyl ErlotinibO-Desmethyl Erlotinib;OSI-420;CP-473420
OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).
价 格:¥电议型 号:T6328产 地:中国大陆
-
T0373LErlotinib hydrochlorideNSC 718781;OSI-744;Erlotinib HCl;CP-358774;盐酸埃罗替尼
Erlotinib is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
价 格:¥电议型 号:T0373L产 地:中国大陆
-
T0373Erlotinib埃罗替尼;NSC 718781;OSI-744;R1415;CP358774
Erlotinib is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
价 格:¥电议型 号:T0373产 地:中国大陆
-
T0373ErlotinibErlotinib,OSI-744,R1415
Erlotinib is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
价 格:¥电议型 号:T0373产 地:美洲
-
T0373LErlotinib hydrochlorideErlotinib hydrochloride,NSC 718781,CP-358774
Erlotinib is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
价 格:¥电议型 号:T0373L产 地:美洲
-
T6619Desmethyl Erlotinib hydrochloride;去甲厄洛替尼OSI420|||OSI-420|||DesMethyl Erlotinib (CP-473420) HCl|||CP-
Desmethyl Erlotinib hydrochloride (OSI 420) is an active metabolite of erlotinib which is an orally active EGFR tyrosin kinase inhibitor with IC50 of 2 and 20 nM for human EGFR and EGFR autophosphorylation in tumor cells.
价 格:¥电议型 号:T6619产 地:中国大陆
-
T6328Desmethyl Erlotinib;化合物Desmethyl ErlotinibOSI-420|||CP-473420|||O-Desmethyl Erlotinib;OSI-420|||CP-4
Desmethyl Erlotinib (CP-473420) is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).
价 格:¥电议型 号:T6328产 地:中国大陆
-
T35915Erlotinib-13C6;Erlotinib-13C6Erlotinib-13C6;Erlotinib-13C6
Erlotinib-13C6 (CP-358774-13C6) is a 13C-labeled Erlotinib. Erlotinib is a directly acting EGFR tyrosine kinase inhibitor, with an IC50 of 2 nM for human EGFR[1].
价 格:¥电议型 号:T35915产 地:中国大陆
-
T31055CP-457493;化合物 T31055OSI-493|||Erlotinib metabolite M6|||CP457493|||UNII-X0JH558S7E;OSI-493|||Erlotin
CP-457493 is a bio-active chemical.
价 格:¥电议型 号:T31055产 地:中国大陆
-
T19312Erlotinib-d6 hydrochloride;化合物 T19312CP-358774 D6 hydrochloride|||NSC 718781 D6 hydrochloride|||Erlo
Erlotinib Hydrochloride inhibits purified EGFR kinase with an IC50 of 2 nM. Erlotinib D6 hydrochloride a deuterium labeled Erlotinib Hydrochloride.
价 格:¥电议型 号:T19312产 地:中国大陆
-
T11229Erlotinib-d6;化合物 T11229OSI-774 D6|||NSC 718781 D6|||CP-358774 D6;OSI-774 D6|||NSC 718781 D6|||CP-358
Erlotinib is a directly acting inhibitor EGFR tyrosine kinase inhibitor with an IC50 of 2 nM for human EGFR. Erlotinib D6 is a deuterium labeled Erlotinib .
价 格:¥电议型 号:T11229产 地:中国大陆
-
T0373L1Erlotinib mesylate;埃罗替尼甲磺酸盐CP-358774|||CP-358,774|||OSI-774|||CP358774|||OSI 774;CP-358774|||CP-358,
Erlotinib is an epidermal growth factor receptor inhibitor. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor.
价 格:¥电议型 号:T0373L1产 地:中国大陆
-
T0373LErlotinib hydrochloride盐酸埃罗替尼盐酸埃罗替尼|||OSI-744|||NSC 718781|||Erlotinib HCl|||CP-358774
Erlotinib hydrochloride (NSC 718781) is an EGFR inhibitor (IC50: 2 nM). It is used for the treatment of non-small cell lung cancer.
价 格:¥电议型 号:T0373L产 地:中国大陆
-
T0373Erlotinib;埃罗替尼OSI-744|||NSC 718781|||CP358774|||R1415;OSI-744|||NSC 718781|||CP358774|||埃罗替尼|||R1415
Erlotinib (CP358774) is a first-generation EGFR inhibitor that inhibits the EGFR 19 Del and L858R mutations. Erlotinib has antitumor activity and is used for the treatment of EGFR-mutated non-small-cell lung cancers. Erlotinib administration results in the development of the EGFR C797S resistance mutation.
价 格:¥电议型 号:T0373产 地:中国大陆